CCL20 and Cholestatic liver disease: Consistent with the findings in a mouse model, patients with cholestatic liver disease showed elevated CCR6 expression, which linked CCL20 to biliary epithelial cells (BECs) (Oo et al., 2012); however, these were considered as Th17-dominated.